Wagey, Frank Mitchell Marvel
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Gambaran pasien mola hidatidosa di RSUP Prof. Dr. R.D. Kandou periode Januari 2020 sampai Desember 2022 Estevania Kaligis; Wantania, John Johannes Ezwchiel; Wagey, Frank Mitchell Marvel
Jurnal Kedokteran Komunitas dan Tropik Vol 12 No 2 (2024)
Publisher : UNIVERSITAS SAM RATULANGI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Hydatidiform mole is a pathological pregnancy characterised by abnormal trophoblastic development, hindering foetal growth. This condition requires a better understanding of enhancing healthcare quality. Aim: To describe the profile of hydatidiform mole patients at Prof. Dr. R.D Kandou General Hospital, Manado, from January 2020 to December 2022. Methods: A quantitative descriptive study with a cross-sectional design was conducted, analysing data from 71 patients. Results: The most common age range was 20-35 years. In terms of parity, 42 patients were multiparous. Of the patients’ highest education level, 40 people had a senior high school level of education. There were 46 patients with haemoglobin levels of more than 11 g/dL. Vaginal bleeding was the most common symptom, which occurred in 48 patients. Conclusion: This study indicates hydatidiform mole predominantly affects women aged 20-35, multiparous, and with senior high school education, furthermore, vaginal bleeding is the most common symptom. These findings can improve awareness and healthcare quality for hydatidiform mole patients. Keywords: hydatidiform mole
Preoperative Platelet-Lymphocyte Ratio as a Prognostic Factor of Epithelial Ovarian Cancer Winata, Johan; Laihad, Bismarck Joel; Wagey, Frank Mitchell Marvel
Indonesian Journal of Obstetrics and Gynecology Volume 11 No. 1 January 2023
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32771/inajog.v11i1.1738

Abstract

Objective: To determine whether platelet-lymphocyte ratio can be a prognostic factor for epithelial ovarian cancer. Methods: This study was a retrospective cohort with analytical design, conducted in the Department of Obstetrics and Gynecology of Prof. Dr. R.D. Kandou Manado General Hospital from January – November 2020. The subjects were all patients with epithelial ovarian cancer who met the inclusion and exclusion criteria. Data analysis was conducted with Chi-square test.Results: 35 subjects were included in this study. Most subjects were 40-50 years and had a platelet-lymphocyte ratio of above 200. The mean platelet-lymphocyte ratio of the subjects with epithelial ovarian cancer was 244.663 +- 130.0234. Chi-square test showed a significant association between platelet-lymphocyte ratio and the ovarian cancer relapse (X2 = 14.464 p = 0.000) with RR=4.0Conclusion: There was a significant difference between platelet-lymphocyte ratio and the ovarian cancer relapse.Keywords: epithelial ovarian cancer, inflammatory marker, platelet-lymphocyte ratio, prognosis.